Mitral valve-in-valve implantation during pregnancy

2021 ◽  
Vol 14 (11) ◽  
pp. e244270
Author(s):  
Mark Zachary Johnson ◽  
Nicholas James Damianopoulos ◽  
Felicity Lee ◽  
Gerald Yong

A 32-year-old, 11-week pregnant African woman with known rheumatic heart disease presented to the emergency department with worsening shortness of breath on exertion. She had undergone a double bioprosthetic valve replacement and left atrial appendage resection 8 years prior for severe mitral stenosis, moderate mitral regurgitation and moderate aortic regurgitation. A transo-oesophageal echocardiography at this presentation confirmed a morphologically calcified and stenosed mitral bioprosthesis, with moderate stenosis of her aortic bioprosthesis. Her multidisciplinary team, including cardiologists, cardiothoracic surgeons and obstetricians, came to a consensus decision to proceed with a transseptal transcatheter valve implantation within the mitral valve prosthesis (valve-in-valve implantation). Transthoracic echocardiography performed 2 months post procedure showed satisfactory mitral valve gradients and at 30 weeks’ gestation, she successfully delivered her fifth child. 2 years later, the valve in valve complex is still functioning well.

2020 ◽  
Vol 24 (1) ◽  
pp. 94
Author(s):  
V. I. Ganyukov ◽  
E. A. Shloido ◽  
R. S. Tarasov ◽  
N. V. Rogulina ◽  
I. K. Khalivopulo ◽  
...  

<p>A clinical case of endovascular correction of a biological mitral valve prosthesis dysfunction by implantation of a transcatheter aortic valve into the mitral position is described. Considering the clinical status of the patient, the condition was determined to be inoperable. Subsequently, based on vital fluoroscopy and echocardiography findings, the patient was implanted with a transcatheter aortic valve in the mitral valve bioprosthesis position. The technical and clinical aspects of the intervention and its results were analysed during the hospital period and for 5 months after implantation. The selected method of treatment was found to be appropriate.</p><p>Received 10 January 2020. Revised 18 March 2020. Accepted 19 March 2020.</p><p><strong>Funding</strong>: The study did not have sponsorship.</p><p><strong>Conflict of interest:</strong> Authors declare no conflict of interest.</p><p><strong>Author contributions</strong><br />Drafting the article: N.V. Rogulina, I.V. Ganyukov, A.M. Kochergina, V.I. Ganyukov, R.S. Tarasov, I.K. Khalivopulo, I.N. Sizova <br />Literature review: V.I. Ganyukov, R.S. Tarasov, N.V. Rogulina, I.K. Khalivopulo, I.V. Ganyukov, A.M. Kochergina <br />Illustrations: I.V. Ganyukov, I.N. Sizova, N.V. Rogulina <br />Critical revision of the article: V.I. Ganyukov, R.S. Tarasov, E.A. Shloido, L.S. Barbarash <br />Surgical treatment: E.A. Shloido, V.I. Ganyukov, R.S. Tarasov<br />Final approval of the version to be published: V.I. Ganyukov, E.A. Shloido, R.S. Tarasov, N.V. Rogulina, I.K. Khalivopulo, I.V. Ganyukov, A.M. Kochergina, I.N. Sizova, L.S. Barbarash</p>


Author(s):  
Nils Perrin ◽  
Hajo Muller ◽  
Stephane Noble

We present hereby the case of a 75-year-old woman with a degenerated mitral bioprosthesis and severely reduced left ventricular ejection fraction who underwent a successful trans-septal mitral valve-in-valve (TMViV) replacement using a 29mm Edwards Sapien S3 transcatheter heart valve. We also performed a literature review.


2014 ◽  
Vol 12 (9) ◽  
pp. 1035-1036 ◽  
Author(s):  
Stamatios Lerakis ◽  
Salim S Hayek ◽  
Vinod Thourani ◽  
Vasilis Babaliaros

Author(s):  
Dee Dee Wang ◽  
Brian P. O'Neill ◽  
Thomas G. Caranasos ◽  
W. Randolph Chitwood ◽  
Richard S. Stack ◽  
...  

2013 ◽  
pp. 661-661
Author(s):  
Tomasz Hirnle ◽  
Sławomir Dobrzycki ◽  
Marek Frank ◽  
Bożena Sobkowicz ◽  
Maciej Mitrosz

Sign in / Sign up

Export Citation Format

Share Document